W.-B. Pan et al. / Tetrahedron Letters 54 (2013) 2655–2657
2657
TMS
TMS
R
I
R
I
TBDMSCl
imidazole
CH2Cl2, rt
Pd(PPh3)4
CuI
R
OH
n-BuNH2
ether, rt
OTBDMS
OTBDMS
2
1
3
1b R = i-Pr
2b (94%)
2c (86%)
2d (74%)
2e (98%)
2f (88%)
2g (87%)
2h (45%)
3b (92%)
3c (88%)
3d (95%)
3e (97%)
3f (97%)
3g (87%)
1c R = C2H5
1d R = CH3
1e R = t-Bu
1f R = Cl
1g R = Br
1h R = NO2
Scheme 3.
R
I
OH
References and notes
R
R
I
chloramine T
NaI
DMF, rt
+
1. (a) Flynn, B. L.; Hamel, E.; Jung, M. K. J. Med. Chem. 2002, 45, 2670; (b) Wallez,
V.; Poissonnier, S. D.; Chavatte, P.; Boutin, J. A.; Audinot, V.; Nicolas, J. P.;
Bennejean, C.; Delagrange, P.; Renard, P.; Lesieur, D. J. Med. Chem. 2002, 45,
2788; (c) Carlsson, B.; Singh, B. N.; Temciuc, M.; Nilsson, S.; Li, Y. L.; Mellin, C.;
Malm, J. J. Med. Chem. 2002, 45, 623.
2. (a) Pacher, T.; Seger, C.; Engelmeier, D.; Vajrodaya, S.; Hofer, O.; Greger, H. J.
Nat. Prod. 2002, 65, 820; (b) Halabalaki, M.; Aligiannis, N.; Papoutsi, Z.;
Mitakou, S.; Moutsatsou, P.; Sekeris, C.; Skaltsounis, A. L. J. Nat. Prod. 2000, 63,
1672; (c) Banskota, A. H.; Tezuka, Y.; Midorikawa, K.; Matsushige, K.; Kadota, S.
J. Nat. Prod. 2000, 63, 1277.
OH
OH
I
1'
1
1b R = i-Pr (42%)
1b' (33%)
1c' (26%)
1d' (20%)
1e' (22%)
1f' (12%)
1g' (6%)
1c R = C2H5 (50%)
1d R = CH3 (69%)
1e R = t-Bu (71%)
1f R = Cl (73%)
1g R = Br (91%)
1h R = NO2 (90%)
3. Malamas, M. S.; Sredy, J.; Moxham, C.; Katz, A.; Xu, W. X.; McDevitt, R.;
Adebayo, F. O.; Sawicki, D. R.; Seestaller, L.; Sullivan, D.; Taylor, J. R. J. Med.
Chem. 2000, 43, 1293.
1h' (trace)
Scheme 4.
4. (a) Kim, S. I.; Park, I. H.; Song, K. S. J. Antibiot. 2002, 7, 623; (b) Song, K. S.;
Raskin, I. J. Nat. Prod. 2002, 65, 76.
5. Dixit, M.; Tripathi, B. K.; Tamrakar, A. K.; Srivastava, A. K.; Kumar, B.; Goel, A.
Bioorg. Med. Chem. 2007, 15, 727.
6. Bakunova, S. M.; Bakunov, S. A.; Wenzler, T.; Barszcz, T.; Werbovetz, K. A.; Brun,
R.; Hall, J. E.; Tidwell, R. R. J. Med. Chem. 2007, 50, 5807.
7. Kirilmis, C.; Koca, M.; Cukurovali, A.; Ahmedzade, M.; Kazaz, C. Molecules 2005,
10, 1399.
8. Andersen, N. G.; Parvez, M.; Keay, B. A. Org. Lett. 2000, 2, 2817.
9. Auzias, M.; Haussinger, D.; Neuburger, M.; Wegner, H. A. Org. Lett. 2011, 13,
474.
10. (a) Shen, Y. D.; Wu, H. Q.; An, L. K.; Huang, Z. S.; Bu, X. Z.; Gu, L. Q. Chin. Chem.
Lett. 2005, 16, 1581; (b) Dixit, M.; Sharon, A.; Maulik, P. R.; Goel, A. Synlett 2006,
1497; (c) Kumar, B.; Dixit, M.; Singh, S. P.; Raghunadan, R.; Maulik, P. R.; Goel,
A. Tetrahedron Lett. 2009, 50, 4335.
TMS
Pd(PPh3)4
CuI
O2N
I
O2N
TMS
O
n-BuNH2
ether, rt
OTBDMS
2h
6 (85%)
Scheme 5.
TMS
11. Do, H. Q.; Daugulis, O. J. Am. Chem. Soc. 2009, 131, 17052.
12. Auzias, M. G.; Neuburger, M.; Wegner, H. A. Synlett 2010, 2443.
13. Bakunov, S. A.; Bakunova, S. M.; Bridges, A. S.; Wenzler, T.; Barszcz, T.;
Werbovetz, K. A.; Brun, R.; Tidwell, R. R. J. Med. Chem. 2009, 52, 5763.
14. Yang, L. Y.; Chang, C. F.; Huang, Y. C.; Lee, Y. J.; Hu, C. C.; Tseng, T. H. Synthesis
2009, 1175.
R
R
R
CuCl, DMF
160oC, 24h
OTBDMS
O
O
3
4
4b (62%)
3b R = i-Pr (92%)
3c R = C2H5 (88%)
3d R = CH3 (95%)
3e R = t-Bu (97%)
3f R = Cl (97%)
3g R = Br (87%)
15. Benincori, T.; Brenna, E.; Sannicolo, F.; Trimacro, L.; Antognazza, P.; Cesarotti,
E.; Demartin, F.; Pilati, T. J. Org. Chem. 1996, 61, 6244.
4c (82%)
4d (75%)
4e (73%)
4f (65%)
4g (65%)
16. General procedure for the preparation of 5,50-disubstituted-2,20-bisbenzofurans: A
slurry
of
the
4-substituted-2-(2-trimethylsilylethynyl)phenyl
tert-
butyldimethylsilyl ether 3a (0.67 mmol) and CuCl (10 mol %) in dry DMF
(10 mL) at 160 °C was stirred for 24 h. After cooling to room temperature,
saturated NaCl(aq) solution was added to the reaction mixture, and extracted
with EtOAc. The combined organic layer was dried over anhydrous MgSO4(s)
After filtration and removal of the solvent, the residue was purified by flash
chromatography to give the product 4a (65%).
.
Scheme 6.
17. Compound 4a (65%) as a white solid: mp = 193–194 °C; 1H NMR (400 MHz,
CDCl3) d 7.65 (dq, 2H, J = 7.6, 0.8 Hz), 7.56 (dd, 2H, J = 8.0, 0.8 Hz), 7. 36 (td, 2H,
J = 7.2, 1.2 Hz), 7. 29 (td, 2H, J = 7.6, 1.2 Hz), 7.17 (d, J = 0.8 Hz, 2H); 13C NMR
(100 MHz, CDCl3) d 155.1, 147.7, 128.5, 125.1, 123.3, 121.4, 111.3, 103.7;
EI(MS) m/z (rel. intensity) 234 (M+, 100), 178 (11), 176 (25); HRMS (ESI-TOF)
Calcd for C16H10O2, 234.0681, Found: 234.0686; Anal. Calcd for C16H10O2: C,
82.04; H, 4.30. Found: C, 81.79; H, 4.98.
18. (a) Kel’in, A. V.; Sromek, A. W.; Gevorgyan, V. A. J. Am. Chem. Soc. 2001, 123,
2074; (b) Yan, B.; Zhou, Y.; Zhang, H.; Chen, J.; Liu, Y. J. Org. Chem. 2007, 72,
7783; (c) Bai, Y.; Zeng, J.; Ma, J.; Liu, W.; Gorityala, B. K.; Liu, X. W. J. Comb.
Chem. 2010, 12, 696; (d) Haley, M. M.; Bell, M. L.; Brand, S. C.; Kimball, D. B.;
Pak, J. J. Tetrahedron Lett. 1997, 38, 7483; (e) Nishihara, Y.; Ikegashira, K.;
Hirabayashi, K.; Ando, J.; Mori, A.; Hiyama, T. J. Org. Chem. 2000, 65, 1780; (f)
Nishihara, Y.; Takemura, M.; Mori, A.; Osakada, K. J. Organomet. Chem. 2001,
620, 282.
notable features of this cascade reaction are its mild reaction con-
ditions, synthetic simplicity, excellent yields, high regioselectivity,
and usage of less expensive CuCl as a catalyst. The application of
this methodology to the preparation of pharmaceutical or material
interest molecules, 2,20-bisbenzofuran analogues, is currently un-
der investigation.
Acknowledgment
We thank the National Science Council of the Republic of China
for the financial support of this program.